Search results for "Alzheimer Disease"

showing 10 items of 428 documents

Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.

2014

Increased neurogenesis has been reported in neurodegenerative disease, but its significance is unclear. In a mouse model of prion disease, Gomez-Nicola et al. detect increased neurogenesis in the dentate gyrus that partially counteracts neuronal loss. Targeting neurogenesis may have therapeutic potential.

AdultMaleAntimetabolites AntineoplasticPatch-Clamp TechniquesTime FactorsPrionsNeurogenesisGenetic VectorsHippocampusTissue BanksBiologyHippocampal formationHippocampusCreutzfeldt-Jakob SyndromePrion DiseasesMiceYoung AdultNeural Stem CellsAlzheimer Diseasevariant CJDNeural PathwaysmedicineAnimalsHumansAgedCell ProliferationDentate gyrusNeurogenesisNeurodegenerationCytarabineNeurodegenerative DiseasesOriginal ArticlesMiddle Agedmedicine.diseaseNeural stem cellMice Inbred C57BLNeuroanatomical Tract-Tracing Techniquesadult neurogenesisDisease Models AnimalChronic DiseaseDentate GyrusMossy Fibers HippocampalDisease ProgressionFemaleNeurology (clinical)Alzheimer's diseaseNeuroscienceNeural developmentAlzheimer’s diseaseBrain : a journal of neurology
researchProduct

Alzheimer's disease: amyloid plaques in the cerebellum

1989

Two specific silver-staining methods demonstrating either extracellular amyloid and/or precursors of amyloid or intraneuronal neurofibrillary changes were used to examine cerebellar pathology in cases of presenile and senile dementia of the Alzheimer type, cases of Down's syndrome, and non-demented controls. The sensitivity of the techniques permitted visualization of large numbers of amyloid deposits in the cerebellar cortex of demented individuals. Similarly large numbers of amyloid deposits were not found in the cerebella of non-demented individuals. Neurofibrillary changes were absent. The majority of amyloid plaques occurred in the molecular layer. Quite a number of these displayed lar…

AdultMaleCerebellumPathologymedicine.medical_specialtyAdolescentAmyloidGranular layerBiologyWhite matterAlzheimer DiseaseCerebellar DiseasesCerebellummental disordersmedicineHumansSenile plaquesAgedAged 80 and overInclusion BodiesAmyloidosisAmyloidosisMiddle Agedmedicine.diseasemedicine.anatomical_structureNeurologyCerebellar cortexFemaleNeurology (clinical)Down SyndromeAlzheimer's diseaseNeuroscienceJournal of the Neurological Sciences
researchProduct

Isolated and Joint Effects of Tobacco and Alcohol Consumption on Risk of Alzheimer's Disease

2010

The roles of smoking and alcohol on the development of Alzheimer's disease (AD) remain unclear. We performed a case-control study on the effects of both exposures before the age of onset of the disease in the cases (and same reference age for their age-matched controls) on disease risk. Interviews were conducted with population controls (n=246) and relatives of cases (n=176) identified through local Alzheimer's Disease Associations. Logistic regression models were built adjusting by gender, age, residence, education, economic situation, employment, and history of dementia in close relatives. Risk of AD was unaffected by any measure of tobacco consumption. Alcohol consumers showed a lower ri…

AdultMaleGerontologymedicine.medical_specialtyAlcohol DrinkingApolipoprotein E4PopulationLower riskLogistic regressionAlzheimer DiseaseRisk FactorsEpidemiologymedicineHumansDementiaeducationAgedAged 80 and overeducation.field_of_studybusiness.industryGeneral NeuroscienceSmokingCase-control studyGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologySpainCase-Control StudiesFemaleGeriatrics and GerontologyAge of onsetbusinessDemographyJournal of Alzheimer's Disease
researchProduct

Familiarity-based recognition in the young, healthy elderly, mild cognitive impaired and Alzheimer's patients

2009

This study investigates the possible existence of deficits in familiarity in five samples of participants spanning a broad range of ages and cognitive states. Five groups of 16 participants with a diagnosis of multi-domain cognitive impairment with a slight or no deficit in memory, 16 multi-domain amnestic, and 16 Alzheimer's disease patients were compared in a recognition test with equivalent samples of old and young healthy participants. In one of the tests, participants studied words extracted from a restricted set of letters of the alphabet that were later mixed with new words from a different set. The unconscious use of the fluency produced by the repeated use of the set of letters was…

AdultMaleMedicina i psicologiaAgingmedicine.medical_specialtyCognitive NeuroscienceExperimental and Cognitive PsychologyNeuropsychological TestsAudiologyChoice BehaviorDevelopmental psychologyYoung AdultBehavioral NeuroscienceFluencyDiscrimination PsychologicalAlzheimer DiseasemedicineHumansDementiaGeriatric AssessmentAgedRecognition memoryAnalysis of VarianceRecallMemoriaNeuropsychologyRecognition PsychologyCognitionmedicine.diseaseFemaleAlzheimer's diseaseCognition DisordersPsychologyPhotic StimulationNeuropsychologia
researchProduct

Working memory and everyday cognition in adults with Down's syndrome.

2001

A number of previous studies have suggested that young people with Down's syndrome (DS) have a specific deficit of the phonological loop component of the working memory. However, there have also been studies which have proposed a specific deficit of the central executive component of working memory and suggested similarities of working memory functioning with patients with Alzheimer's disease. Fifteen middle-aged people with DS were matched for their individual scores of non-verbal intelligence to 15 individuals with mixed aetiology of intellectual disability. A versatile range of tasks was used in order to evaluate the functioning of working memory components. In addition, several everyday…

AdultMalemedia_common.quotation_subjectNeuropsychological TestsSerial LearningAffect (psychology)Developmental psychologyArts and Humanities (miscellaneous)Visual memoryAlzheimer DiseasePhoneticsPerceptionIntellectual disabilityActivities of Daily LivingmedicineHumansAttentionmedia_commonWorking memoryRehabilitationRetention PsychologyCognitionMiddle AgedVerbal Learningmedicine.diseasePsychiatry and Mental healthNeurologyPattern Recognition VisualMental RecallFemaleNeurology (clinical)Baddeley's model of working memoryChildhood memoryDown SyndromePsychologyPsychomotor PerformanceJournal of intellectual disability research : JIDR
researchProduct

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.

2003

Experimental and clinical studies give evidence for breakdown of membrane phospholipids during neurodegeneration. In the present study, we measured the levels of glycerophosphocholine (GPCh), phosphocholine (PCh), and choline, that is, water-soluble metabolites of phosphatidylcholine (PtdCho), in human cerebrospinal fluid (CSF). Among 30 cognitively normal patients the average CSF levels of GPCh, phosphocholine and choline were 3.64, 1.28, and 1.93 microM, respectively; metabolite levels did not change with increasing age. When compared with age-matched controls, patients with Alzheimer's disease had elevated levels of all choline metabolites: GPCh was significantly increased by 76% (P<0.01…

AdultMalemedicine.medical_specialtyAgingAdolescentMetabolitePhosphorylcholineCholinechemistry.chemical_compoundPhospholipase A2Cerebrospinal fluidAlzheimer DiseasePhosphatidylcholineInternal medicinemedicineCholineHumansVascular dementiaPhosphocholineAgedAged 80 and overbiologyPhosphorylcholineGeneral NeuroscienceDementia VascularAge FactorsMiddle Agedmedicine.diseaseGlycerylphosphorylcholineEndocrinologychemistryImmunologybiology.proteinFemaleNeurology (clinical)Geriatrics and GerontologyBiomarkersDevelopmental BiologyNeurobiology of aging
researchProduct

MRS SHOWS ABNORMALITIES BEFORE SYMPTOMS IN FAMILIAL ALZHEIMER DISEASE

2006

Background: Pathologic change in Alzheimer disease (AD) begins some years before symptoms. MRS has the potential to detect metabolic abnormalities reflecting this early pathologic change. Presenilin 1 (PS1) and amyloid precursor protein (APP) mutation carriers have a nearly 100% risk of developing AD and may be studied prior to symptom onset. Methods: Short echo time proton MR spectra were acquired from a midline posterior cingulate voxel in presymptomatic carriers of PS1 or APP mutations (“presymptomatic mutation carriers” [PMCs]; n = 7) and age- and sex-matched control subjects (n = 6). Ratios of N-acetyl aspartate (NAA), myo-inositol (MI), and choline-containing compounds (Cho) to creati…

AdultMalemedicine.medical_specialtyPathologyMagnetic Resonance SpectroscopyAlzheimer disease brain metabolism nuclear magnetic resonance spectroscopyAdolescentNeuropsychological TestsCreatineGastroenterologyPresenilinCentral nervous system diseasechemistry.chemical_compoundDegenerative diseaseAlzheimer DiseaseReference ValuesInternal medicinemental disordersmedicineHumansFamilySymptom onsetAge of OnsetChildSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaBrainInfantMiddle Agedmedicine.diseaseControl subjectsnervous system diseasesnervous systemchemistryChild PreschoolCarrier StateFemaleNeurology (clinical)Alzheimer's diseaseGeometric meanPsychology
researchProduct

Volatile organic compounds fingerprint of Alzheimer’s disease.

2015

Alzheimer's disease (AD) is a profoundly life changing condition and once diagnosis occurs, this is typically at a relatively late stage into the disease process. Therefore, a shift to earlier diagnosis, which means several decades before the onset of the typical manifestation of the disease, will be an important step forward for the patient. A promising diagnostic and screening tool to answer this purpose is represented by breath and exhaled volatile organic compounds (VOCs) analysis. In fact, human exhaled breath contains several thousand of VOCs that vary in abundance and number in correlation with the physiological status. The exhaled VOCs reflect the metabolism, including the neuronal …

AdultPulmonary and Respiratory MedicinePathologymedicine.medical_specialtyTime FactorsPhysiologyDiseaseVolatile organic compounds (VOCs)Neurodegenerative diseaseAlzheimer's disease; Breath analysis; Neurodegenerative disease; VOC fingerprint; VOC real time analysis; Volatile organic compounds (VOCs); Adult; Aged; Aged 80 and over; Alzheimer Disease; Biomarkers; Breath Tests; Humans; Middle Aged; Respiratory Rate; Time Factors; Volatile Organic Compounds; Young Adult; Neuroscience (all); Physiology; Pulmonary and Respiratory MedicineYoung AdultRespiratory RateAlzheimer DiseaseVOC fingerprintmedicine80 and overHumansDisease processScreening toolAgedAged 80 and overVolatile Organic CompoundsNeuroscience (all)ChemistryGeneral NeuroscienceLate stageBreath analysisAlzheimer's diseaseMiddle AgedAlzheimer's disease; Breath analysis; Neurodegenerative disease; VOC fingerprint; VOC real time analysis; Volatile organic compounds (VOCs)Breath gas analysisBreath TestsImmunologyVOC real time analysisBiomarkers
researchProduct

Double Negative (CD19+IgG+IgD-CD27-) B Lymphocytes: A New Insight from Telomerase in Healthy Elderly, in Centenarian Offspring, and in Alzheimer’s Di…

2014

Background: We have previously reported the increase of IgD-CD27- (Double Negative, DN) B cell population in the aged. These memory B cells have short telomeres and poor abilities to proliferate in vitro. Here, we investigated whether the low ability of DN B cells to proliferate depends on the expression levels of the CD307d and CD22 inhibitory receptors or whether DN B cells can proliferate and reactivate telomerase by the engagement of both innate and adaptive immune receptors. Methods: Phenotypic analyses were made by using flow cytometry. Quantitative analysis of telomerase activity was made by using a TRAP and a photometric enzyme immunoassay in young, healthy elderly, centenarian offs…

AdultTelomeraseAgingImmunologyPopulationNaive B cellB-Lymphocyte SubsetsReceptors Antigen B-CellCentenarian offspringLymphocyte ActivationSeverity of Illness IndexCD19ImmunophenotypingYoung AdultAlzheimer DiseasemedicineIgD-CD27- (Double Negative DN) B cell population in the aged DN B cell telomerase activity in young elderly CO and AD patientsImmunology and AllergySettore MED/05 - Patologia ClinicaHumanseducationTelomeraseB cellCellular SenescenceAgedInflammationSettore MED/04 - Patologia GeneraleAged 80 and overeducation.field_of_studyCD40biologyB lymphocyteAge FactorsTLR9ImmunosenescenceMiddle Agedmedicine.anatomical_structurePhenotypeImmunologyAntigens Surfacebiology.proteinAlzheimerAging; Telomerase; B lymphocytes; Alzheimer; Centenarian offspring; InflammationSettore MED/26 - NeurologiaImmunologic Memory
researchProduct

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease

2015

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the charac…

Aged 80 and overMaleMILD COGNITIVE IMPAIRMENTScience & TechnologyPREDICTIONGeneral Science & TechnologyNormal DistributionBrainModels TheoreticalDIAGNOSISSensitivity and SpecificityMultidisciplinary SciencesPETAlzheimer DiseaseFluorodeoxyglucose F18Positron-Emission TomographyMD MultidisciplinaryHumansScience & Technology - Other TopicsFemaleRadiopharmaceuticalsResearch ArticleAged
researchProduct